Evaluation of Swallowing by Sydney Swallow Questionnaire (SSQ) in Oral and Oropharyngeal Cancer Patients Treated with Primary Surgery
Overview
Authors
Affiliations
This work aimed at evaluating patients' swallowing functions by a newly validated swallow-specific questionnaire, the Sydney Swallow Questionnaire (SSQ), in a cohort of oral and oropharyngeal cancer patients. Mean/median SSQ scores were calculated and compared with study variables using the Mann-Whitney U test and Kruskal-Wallis test. The mean composite SSQ scores (SD) for the base of tongue, oral tongue, and tonsillar cancer patients were 663.8 (382.8), 456.2 (407.6), and 283.0 (243.1), respectively (p = 0.005); for advanced vs. early T stage disease they were 918.1 (319.5) vs. 344.8 (292.1) (p ≤ 0.001); for patients <60 years vs. ≥60 years they were 549.3 (415.1) vs. 314.0 (247.3) (p = 0.02); and for patients with reconstruction vs. without reconstruction they were 676.5 (410.5) vs. 331.9 (286.5) (p = 0.002). SSQ is a useful tool for evaluation of swallowing in head and neck cancer patients. Site of cancer, T stage, patient's age, and reconstruction directly affect post-treatment swallow outcome.
Adaptation and Validation of the Sydney Swallow Questionnaire into Kannada (KSSQ).
Narasimhan S, Divyashree D Dysphagia. 2024; 40(2):454-463.
PMID: 39249512 DOI: 10.1007/s00455-024-10748-5.
Audag N, Liistro G, Vandervelde L, van den Bogaert E, Toussaint M, Reychler G Indian J Otolaryngol Head Neck Surg. 2024; 76(3):2361-2366.
PMID: 38883452 PMC: 11169218. DOI: 10.1007/s12070-024-04484-3.
The Chinese version of the Ohkuma questionnaire: reliability analysis and diagnostic value.
Pingping Z, Dezhi L, Tingting L, Hui Z, Huan L, Xiaowen W Acta Neurol Belg. 2024; 124(6):1831-1838.
PMID: 38722526 DOI: 10.1007/s13760-024-02525-w.
Systematic review of risk factors of postoperative dysphagia in patients with oral cancer.
Lu Q, Guo L, Bi X Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 40(3):328-334.
PMID: 38597015 PMC: 9207793. DOI: 10.7518/hxkq.2022.03.013.
Swallowing after Oral Oncological Treatment: A Five-Year Prospective Study.
Speksnijder C, Ortiz-Comino L, de Haan A, Fernandez-Lao C, de Bree R, Merkx M Cancers (Basel). 2023; 15(17).
PMID: 37686646 PMC: 10486578. DOI: 10.3390/cancers15174371.